Stay updated on Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page.

Latest updates to the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedThe government funding status banner at the top of the study record page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedNo significant changes were detected on the Study Details page for NCT02545504; the content and layout appear consistent with the previous version.SummaryDifference0.2%

- Check46 days agoChange DetectedUpdated the page version from v3.0.2 to v3.2.0.SummaryDifference0.1%

- Check47 days agoChange DetectedUpdate to a newer revision tag (from v3.0.2 to v3.1.0); no substantive changes to core content or user-facing data.SummaryDifference0.1%

- Check54 days agoChange DetectedRemoved explicit mentions of Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, and Substandard Drugs; overall content framing in the safety/quality area appears diminished.SummaryDifference0.2%

- Check61 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top link was removed. This is a minor release with limited visible impact.SummaryDifference0.2%

Stay in the know with updates to Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page.